These results not only offer a novel perspective on the molecular mechanisms of cervical cancer but also provide a theoretical foundation for the development of precision therapies targeting non-coding RNAs (e.g., inhibiting SNORD6 or SNHG12), particularly in overcoming radioresistance. This evidence concerns the gene SNORD6 and cervical carcinoma.